|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 3/12/20 Biosynergy Inc 10-Q 1/31/20 41:1.1M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 124K
2: EX-31.1 Certification of Chief Executive Officer HTML 18K
3: EX-31.2 Certification of Chief Accounting Officer HTML 18K
5: EX-32 Certification -- §906 - SOA'02 HTML 13K
4: EX-32.1 Certification Pursuant to 18 U.S.C. Section 1350 HTML 13K
as Adopted
27: R1 Document and Entity Information HTML 45K
38: R2 Balance Sheets (Unaudited) HTML 101K
34: R3 Balance Sheets (Parenthetical) HTML 21K
16: R4 Statements of Operations (Unaudited) HTML 57K
26: R5 Statements of Cash Flows (Unaudited) HTML 66K
37: R6 Shareholders Equity (Unaudited) HTML 24K
33: R7 Company Organization and Description HTML 19K
15: R8 Summary of Significant Accounting Policies HTML 40K
28: R9 Inventories HTML 19K
14: R10 Common Stock HTML 16K
24: R11 Related Party Transactions HTML 24K
36: R12 Lease Commitments HTML 18K
32: R13 Customer Concentration HTML 19K
13: R14 Depreciation HTML 16K
23: R15 Research and Development and Patents HTML 17K
35: R16 Summary of Significant Accounting Policies HTML 88K
(Policies)
31: R17 Summary of Significant Accounting Policies HTML 23K
(Tables)
12: R18 Inventories (Tables) HTML 20K
25: R19 Related Party Transactions (Tables) HTML 22K
40: R20 Summary of Significant Accounting Policies - HTML 27K
Income Tax Rate (Details)
30: R21 Summary of Significant Accounting Policies - HTML 23K
Provision for Income Taxes (Details)
18: R22 Depreciation (Details Narrative) HTML 16K
22: R23 Research and Development and Patents (Details HTML 17K
Narrative)
39: R24 Inventories - Inventories (Details) HTML 22K
29: R25 Related Party Transactions (Details Narrative) HTML 22K
17: R26 Lease Commitments - Future Minimum Lease Expense HTML 20K
(Details)
21: R27 Customer Concentrations (Details) HTML 21K
41: XML IDEA XML File -- Filing Summary XML 64K
20: EXCEL IDEA Workbook of Financial Reports XLSX 31K
11: EX-101.INS XBRL Instance -- bsyn-20200131 XML 236K
7: EX-101.CAL XBRL Calculations -- bsyn-20200131_cal XML 98K
8: EX-101.DEF XBRL Definitions -- bsyn-20200131_def XML 56K
9: EX-101.LAB XBRL Labels -- bsyn-20200131_lab XML 304K
10: EX-101.PRE XBRL Presentations -- bsyn-20200131_pre XML 223K
6: EX-101.SCH XBRL Schema -- bsyn-20200131 XSD 55K
19: ZIP XBRL Zipped Folder -- 0000715812-20-000002-xbrl Zip 41K
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Report of Biosynergy, Inc. (the "Company") on Form 10-Q for the quarter ending January 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of 1934, as amended; and
(2) the information contained in the Report fairly represents, in all material respects, the financial conditions and results of operations of the Company as of January 31, 2020, and for the period then ended.
Biosynergy, Inc.
| /s/ Laurence C. Mead |
|
Laurence C. Mead Vice President/Manufacturing and Development, Chief Financial Officer and Chief Accounting Officer |
Dated: March 12, 2020
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/12/20 | None on these Dates | ||
| For Period end: | 1/31/20 | |||
| List all Filings | ||||